Paper33552145
A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers.
Ren J and 6 others. Front Genet, 2020. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers. Papers, record 33552145. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33552145
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20940398 | CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. | Cancer Res | 2010 | https://conductscience.org/library/papers/20940398 | PubMed |
| 2 | 9164203 | Prognostic importance of thymidylate synthase expression in early breast cancer. | J Clin Oncol | 1997 | https://conductscience.org/library/papers/9164203 | PubMed |
| 3 | 25822800 | Robust enumeration of cell subsets from tissue expression profiles. | Nat Methods | 2015 | https://conductscience.org/library/papers/25822800 | PubMed |
| 4 | 31594212 | Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma. | Cancer Biomark | 2019 | https://conductscience.org/library/papers/31594212 | PubMed |
| 5 | 25428505 | PD-1 blockade induces responses by inhibiting adaptive immune resistance. | Nature | 2014 | https://conductscience.org/library/papers/25428505 | PubMed |
| 6 | 25428504 | Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. | Nature | 2014 | https://conductscience.org/library/papers/25428504 | PubMed |
| 7 | 31558162 | Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers. | J Transl Med | 2019 | https://conductscience.org/library/papers/31558162 | PubMed |
| 8 | 23180760 | Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. | Nucleic Acids Res | 2013 | https://conductscience.org/library/papers/23180760 | PubMed |
| 9 | 21487406 | Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21487406 | PubMed |
| 10 | 17320505 | The mammalian epigenome. | Cell | 2007 | https://conductscience.org/library/papers/17320505 | PubMed |
| 11 | 19114008 | WGCNA: an R package for weighted correlation network analysis. | BMC Bioinformatics | 2008 | https://conductscience.org/library/papers/19114008 | PubMed |
| 12 | 18815398 | Lung cancer. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18815398 | PubMed |
| 13 | 28961746 | ChAMP: updated methylation analysis pipeline for Illumina BeadChips. | Bioinformatics | 2017 | https://conductscience.org/library/papers/28961746 | PubMed |
| 14 | 20970877 | TS expression predicts postoperative recurrence in adenocarcinoma of the lung. | Lung Cancer | 2011 | https://conductscience.org/library/papers/20970877 | PubMed |
| 15 | 20808728 | Regularization Paths for Generalized Linear Models via Coordinate Descent. | J Stat Softw | 2010 | https://conductscience.org/library/papers/20808728 | PubMed |
| 16 | 30370535 | Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30370535 | PubMed |
| 17 | 27484806 | A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations. | J Biomed Sci | 2016 | https://conductscience.org/library/papers/27484806 | PubMed |
| 18 | 29942092 | Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. | Nat Med | 2018 | https://conductscience.org/library/papers/29942092 | PubMed |
| 19 | 17008531 | Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. | Science | 2006 | https://conductscience.org/library/papers/17008531 | PubMed |
| 20 | 28900490 | Wnt3a Expression Is Associated with Epithelial-Mesenchymal Transition and Impacts Prognosis of Lung Adenocarcinoma Patients. | J Cancer | 2017 | https://conductscience.org/library/papers/28900490 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42866153 | TMEM171 is a potential biomarker associated with lung injury and lung adenocarcinoma. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42866153 | PubMed |
| 41928513 | Development and validation of a 5mC-based prognostic model for lung adenocarcinoma survival. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41928513 | PubMed |
| 41836445 | Integrated multi-omics profiling reveals immune-related biomarkers and regulatory networks for early prediction of tuberculosis in type 2 diabetes mellitus. | Front Immunol | 2026 | https://conductscience.org/library/papers/41836445 | PubMed |
| 41664704 | The mechanism and clinical significance of FKBP5 gene DNA methylation in various psychiatric, metabolic and tumor-related diseases. | Front Genet | 2026 | https://conductscience.org/library/papers/41664704 | PubMed |
| 41596760 | A Decade-Old Atlas of TMEM (Transmembrane) Protein Family in Lung Cancer: Lessons Learnt and Future Directions. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596760 | PubMed |
| 41495694 | Elevated levels of SLC38A1 are correlated with an unfavorable prognosis, as well as accelerated cell proliferation and metastasis in lung adenocarcinoma. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41495694 | PubMed |
| 40352269 | Development of an immune-related gene signature applying Ridge method for improving immunotherapy responses and clinical outcomes in lung adenocarcinoma. | PeerJ | 2025 | https://conductscience.org/library/papers/40352269 | PubMed |
| 40235745 | Integrated radiomics and immune infiltration analysis to decipher immunotherapy efficacy in lung adenocarcinoma. | Quant Imaging Med Surg | 2025 | https://conductscience.org/library/papers/40235745 | PubMed |
| 39149514 | New insight into the CNC-bZIP member, NFE2L3, in human diseases. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39149514 | PubMed |
| 39148981 | Silencing of spindle apparatus coiled-coil protein 1 suppressed the progression of hepatocellular carcinoma through farnesyltransferase-beta and increased drug sensitivity. | Heliyon | 2024 | https://conductscience.org/library/papers/39148981 | PubMed |
| 39040257 | Construction of a circadian rhythm-relevant gene signature for hepatocellular carcinoma prognosis, immunotherapy and chemosensitivity prediction. | Heliyon | 2024 | https://conductscience.org/library/papers/39040257 | PubMed |
| 38748299 | GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration. | Cancer Immunol Immunother | 2024 | https://conductscience.org/library/papers/38748299 | PubMed |
| 37814076 | Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma. | Cell Oncol (Dordr) | 2024 | https://conductscience.org/library/papers/37814076 | PubMed |
| 37239150 | A Deep Learning Approach for Prognostic Evaluation of Lung Adenocarcinoma Based on Cuproptosis-Related Genes. | Biomedicines | 2023 | https://conductscience.org/library/papers/37239150 | PubMed |
| 36969985 | Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma. | Genet Res (Camb) | 2023 | https://conductscience.org/library/papers/36969985 | PubMed |
| 36551790 | Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma. | Biomedicines | 2022 | https://conductscience.org/library/papers/36551790 | PubMed |
| 36536645 | A Novel Gene Signature Associated with Inflammatory Responses and Immune Status Assists in Prognosis and Intervention for Patients with HCC. | J Inflamm Res | 2022 | https://conductscience.org/library/papers/36536645 | PubMed |
| 36334248 | Gene Expression in Bronchial Epithelial Cell Responses to Vanadium Exposure. | Biol Trace Elem Res | 2023 | https://conductscience.org/library/papers/36334248 | PubMed |
| 36119068 | A robust CD8+ T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36119068 | PubMed |
| 36091687 | Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36091687 | PubMed |
Genes44
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33552145
GET https://conductscience.org/api/papers/v1/33552145/references?page=2